Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05090839 · ClinicalTrials.gov registry record · NA

Expressing Personal Recollections in English or Spanish to Alleviate Traumatic Emotions (Exprésate)

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05090839: Completed NA study, sponsored by University of Miami.

NCT05090839 is a NA study that has completed, run by University of Miami. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05090839, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The purpose of this study is to test if expressive writing about traumatic events has positive changes in women living with post-traumatic stress.

Primary Outcome

22-item self-report instrument that corresponds to Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of PTSD over last 7 days on a scale from 0 (not at all) to 4 (extremely) The IES has a total score ranging from 0 to 88 with the higher score indicating greater PTSD symptoms. The IES was assessed before and after the intervention and the change in score (mean and SD) is reported as the outcome measure.

Interventions

  • BEHAVIORAL Weekly Emotional Disclosure (WED)
  • BEHAVIORAL Weekly Emotional Disclosure (WED) Spanish

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-08-18
Est. Completion 2023-12-02
Phase NA
University of Miami

721 total trials

What the finished NCT05090839 record still lists

NCT05090839 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Weekly Emotional Disclosure (WED) is the first listed.

NCT05090839 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05090839 about?

NCT05090839 is a clinical study titled "Expressing Personal Recollections in English or Spanish to Alleviate Traumatic Emotions (Exprésate)". The purpose of this study is to test if expressive writing about traumatic events has positive changes in women living with post-traumatic stress.

What is the current status of trial NCT05090839?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-08-18. Estimated completion is 2023-12-02.

What interventions are being tested in trial NCT05090839?

The interventions under investigation include: Weekly Emotional Disclosure (WED) (BEHAVIORAL), Weekly Emotional Disclosure (WED) Spanish (BEHAVIORAL).

Who is sponsoring clinical trial NCT05090839?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05090839's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05090839, the US trial registry maintained by the National Library of Medicine. NCT05090839 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.